CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Close
186.28
0.360 0.193%
Share volume: 7,573
Last Updated: Thu 26 Dec 2024 08:29:57 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$185.92
0.36
0.19%
Fundamental analysis
44%
Profitability
30%
Dept financing
43%
Liquidity
62%
Performance
55%
Performance
5 Days
0.49%
1 Month
-5.80%
3 Months
-6.04%
6 Months
-9.88%
1 Year
-21.78%
2 Year
-14.74%
Key data
Stock price
$186.28
DAY RANGE
$184.52 - $187.09
52 WEEK RANGE
$181.23 - $275.00
52 WEEK CHANGE
-$21.98
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: James C. Foster
Region: US
Website: criver.com
Employees: 21,400
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: criver.com
Employees: 21,400
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services. The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies. The Manufacturing segment provides in vitro testing of sterile and non-sterile pharmaceuticals and consumer products.
Recent news